Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using endopredict, an integrated 12-gene clinicomolecular assay
Hatem Soliman, Darl D. Flake, Anthony Magliocco, Mark Robson, Lee Schwartzberg, Priyanka Sharma, Krystal Brown, Saskia Wehnelt, Ralf Kronenwett, Alexander Gutin, Johnathan Lancaster, Jack Cuzick, William Gradishar*
Dive into the research topics of 'Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using endopredict, an integrated 12-gene clinicomolecular assay'. Together they form a unique fingerprint.